<DOC>
	<DOCNO>NCT00844779</DOCNO>
	<brief_summary>Non alcoholic fatty liver disease ( NAFLD ) represent two main pathological condition , hepatic steatosis ( HS ) non alcoholic steatohepatitis ( NASH ) , characterize accumulation fat liver . The diagnosis two entity achieve histology neither image biochemical marker accurate enough discriminate . At contrary HS , NASH feature hepatocyte necrosis , inflammation fibrosis variable intensity could progress ultimately evolve cirrhosis . Therefore , important distinguish HS NASH order treat patient accordingly . In study , investigator aim understand molecular mechanism govern transition benign steatosis complicate NASH . The investigator analyze `` Q-RT-PCR '' `` DNA microarray '' technology liver obese patient , expression gene susceptible involved pathogenesis NAFLD identify potential signal pathway responsible progression disease .</brief_summary>
	<brief_title>Molecular Investigation Non Alcoholic Fatty Liver Diseases Obese Patients</brief_title>
	<detailed_description />
	<mesh_term>Liver Diseases</mesh_term>
	<mesh_term>Fatty Liver</mesh_term>
	<mesh_term>Non-alcoholic Fatty Liver Disease</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Liver Extracts</mesh_term>
	<criteria>Group T ( n=30 ) : patient without central adiposity , without insulin resistance , operate cholecystectomy benign liver tumor Group A ( n=30 ) : patient central adiposity , insulin resistance hepatic steatosis ( histology ) . Group B ( n=30 ) : patient central adiposity , insulin resistance steatohepatitis Â± hepatic fibrosis ( histology ) . viral autoimmune hepatitis hematochromatosis alcohol consumption ( &gt; 20 g/24h woman , &gt; 30 g/24h men ) type 1 diabetes inflammation infection procedure abnormal hemostasis coagulation pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>April 2009</verification_date>
	<keyword>Metabolic syndrome- hepatic steatosis- steatohepatitis - gene expression</keyword>
	<keyword>Non alcoholic fatty liver disease ( NFALD )</keyword>
</DOC>